ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.04B
Enterprise Value 31.69B
Trailing P/E N/A
Forward P/E 1-24.74
PEG Ratio (5 yr expected) 1-0.25
Price/Sales (ttm)12.86
Price/Book (mrq)6.70
Enterprise Value/Revenue 310.68
Enterprise Value/EBITDA 6-6.62

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin -161.44%
Operating Margin (ttm)-163.11%

Management Effectiveness

Return on Assets (ttm)-37.83%
Return on Equity (ttm)-67.18%

Income Statement

Revenue (ttm)158.48M
Revenue Per Share (ttm)1.28
Quarterly Revenue Growth (yoy)219.70%
Gross Profit (ttm)111.84M
EBITDA -255.67M
Net Income Avi to Common (ttm)-255.86M
Diluted EPS (ttm)-2.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.06M
Total Cash Per Share (mrq)2.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.38
Book Value Per Share (mrq)2.44

Cash Flow Statement

Operating Cash Flow (ttm)-192.53M
Levered Free Cash Flow (ttm)-99.96M

Trading Information

Stock Price History

Beta 3.97
52-Week Change 3-45.45%
S&P500 52-Week Change 312.77%
52 Week High 341.20
52 Week Low 314.51
50-Day Moving Average 317.52
200-Day Moving Average 323.89

Share Statistics

Avg Vol (3 month) 33.2M
Avg Vol (10 day) 33.64M
Shares Outstanding 5124.83M
Float 97.5M
% Held by Insiders 10.14%
% Held by Institutions 1105.57%
Shares Short 312.62M
Short Ratio 35.43
Short % of Float 316.02%
Shares Short (prior month) 313.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A